top of page
Aug 22, 2024
PSMA theranostics

Jeremie Calais, MD PhD CPI

Updates on radiopharmaceutical imaging and therapy targeting the Prostate Specific Membrane Antigen (PSMA). PLUVICTO, LOCAMETZ, ILLUCCIX, PSOLUMA PYLARIFY and more …

PSMA theranostics

Dr. Jeremie Calais is a French nuclear medicine physician specialized in cancer imaging and theranostics who joined UCLA in 2016. He is an Associate Professor in the Department of Molecular and Medical Pharmacology and he serves as the director of the UCLA Theranostics Program and the director of the Clinical Research Program of the Ahmanson Translational Theranostics Division.

Jeremie Calais, MD PhD CPI

bottom of page